MarketInOut Stock Screener Log In | Sign Up

Nexstim Oyj

HEL • Healthcare • Medical Devices • Quote as of 10/30/2026
Nexstim Oyj stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeHEL
Market Capitalization62.51 mln
Float3.96 mln
Earnings Date02/26/2027

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.75
Likely reliable

Relative Strength

60 / 100
Outperforming

Debt / Equity

0.41
Low leverage

Pre-Tax Margin

0%
Break-even

ROE

0.94
Very low

Business Description

Nexstim is a Finnish medical technology company that has developed a precise, non-invasive brain stimulation system used to map speech and motor functions before surgery, treat depression and chronic pain, and support recovery after neurological injury. The company sells its systems primarily to universities and teaching hospitals across Europe, North America, and other international markets. Nexstim also works with partners, including Sinaptica Therapeutics and Brainlab, to expand the reach of its technology into new areas such as Alzheimer's disease treatment and advanced brain mapping.

Key Fundamentals

EPS-0.02
ROE0.94
RPS1.59
ROIC5.04
ROA0.35
Interest Cover1.04
EBITDA, mln1.76
EV / EBITDA42.42
EV / EBIT126
Revenue, mln11.69
EV / Revenue6.39

Quote Details

Last 8.80
Change -0.07 (-0.79%)
Open 8.91
Volume 2,239
Turnover 19,703
Average Volume 3,698.52

Financial Ratios

Pre-Tax Profit Margin0
Leverage Ratio1.95
Current Ratio1.65
Price / Book8.15
Price / Tangible Book18.00
Price / Cash Flow97.53
Debt / Equity0.41
Price / Sales6.65

Financial Strength

Altman Z-Score0.67
Piotroski F-Score 6 / 9
Beneish M-Score-2.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.85% 74 / 100   
1 Month -7.07% 36 / 100   
2 Months -8.43% 41 / 100   
6 Months -2.22% 58 / 100   
1 Year -36.69% 15 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog